Potential of Osteoclasts in Calci fi ed Human Aortic Valves

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ajp.amjpathol.org 63 64 65 66 67 68 69 70 71 72 73 74 75 76 Interferon-g Released by Activated CD8 T Lymphocytes Impairs the Calcium Resorption 77 78 79 80 81 82 Potential of Osteoclasts in Calcified Human Aortic Valves Edit Nagy,*yz Yang Lei,* Eduardo Martínez-Martínez,* Simon C. Body,x{ Florian Schlotter,* Michael Creager,* Alexander Assmann,*k Kamal Khabbaz,** Peter Libby,* Göran K. Hansson,y and Elena Aikawa*

[1]  R. Mitchell,et al.  Osseous and chondromatous metaplasia in calcific aortic valve stenosis. , 2016, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[2]  E. Aikawa,et al.  Cardiovascular Development and Disease N-acetylglucosamine-1-phosphate Transferase Suppresses Lysosomal Hydrolases in Dysfunctional Osteoclasts: a Potential Mechanism for Vascular Calcification , 2022 .

[3]  S. Body,et al.  Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease. , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[4]  E. Ingelsson,et al.  Valvular osteoclasts in calcification and aortic valve stenosis severity. , 2013, International journal of cardiology.

[5]  D. Towler.  Molecular and cellular aspects of calcific aortic valve disease. , 2013, Circulation research.

[6]  P. Libby,et al.  Immune effector mechanisms implicated in atherosclerosis: from mice to humans. , 2013, Immunity.

[7]  R. Aurora,et al.  Osteoclasts and CD8 T Cells Form a Negative Feedback Loop That Contributes to Homeostasis of Both the Skeletal and Immune Systems , 2013, Clinical & developmental immunology.

[8]  R. Aurora,et al.  Osteoclast Activated FoxP3+ CD8+ T-Cells Suppress Bone Resorption in vitro , 2012, PloS one.

[9]  Jing Cheng,et al.  Molecular mechanisms of the biphasic effects of interferon-γ on osteoclastogenesis. , 2012, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[10]  K. Teo,et al.  Lipid lowering on progression of mild to moderate aortic stenosis: meta-analysis of the randomized placebo-controlled clinical trials on 2344 patients. , 2011, The Canadian journal of cardiology.

[11]  R. Winchester,et al.  Circulating Activated and Effector Memory T Cells Are Associated with Calcification and Clonal Expansions in Bicuspid and Tricuspid Valves of Calcific Aortic Stenosis , 2011, The Journal of Immunology.

[12]  John Andersson,et al.  Adaptive immunity and atherosclerosis. , 2010, Clinical immunology.

[13]  J. Chambers,et al.  Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[14]  Timur Shtatland,et al.  Osteogenesis Associates With Inflammation in Early-Stage Atherosclerosis Evaluated by Molecular Imaging In Vivo , 2007, Circulation.

[15]  R. Winchester,et al.  The Lymphocytic Infiltration in Calcific Aortic Stenosis Predominantly Consists of Clonally Expanded T Cells1 , 2007, The Journal of Immunology.

[16]  Ralph Weissleder,et al.  Multimodality Molecular Imaging Identifies Proteolytic and Osteogenic Activities in Early Aortic Valve Disease , 2007, Circulation.

[17]  V. Katavic,et al.  Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down‐regulation of receptor activator of nuclear factor‐kappaB and c‐Fos , 2006, Clinical and experimental immunology.

[18]  J. Gardin,et al.  Burden of valvular heart diseases: a population-based study , 2006, The Lancet.

[19]  R. de Caterina,et al.  Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis. , 2004, Journal of the American College of Cardiology.

[20]  Hyun-Man Kim,et al.  Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8+ T cells , 2001, European journal of immunology.

[21]  N. Kamatani,et al.  Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. , 2001, Arthritis and rheumatism.

[22]  Emile R. Mohler,et al.  Bone Formation and Inflammation in Cardiac Valves , 2001, Circulation.

[23]  G. Porenta,et al.  Predictors of outcome in severe, asymptomatic aortic stenosis , 2001 .

[24]  Hiroshi Takayanagi,et al.  T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ , 2000, Nature.

[25]  JanNilsson,et al.  Presence of Oxidized Low Density Lipoprotein in Nonrheumatic Stenotic Aortic Valves , 1999 .

[26]  Sheila J. Jones,et al.  Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Catherine M. Otto,et al.  Clinical Factors Associated With Calcific Aortic Valve Disease , 1997 .

[28]  Bonnie K. Lind,et al.  Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. , 1997, Journal of the American College of Cardiology.

[29]  M. Rosenqvist,et al.  Expression of HLA-DR antigen and smooth muscle cell differentiation markers by valvular fibroblasts in degenerative aortic stenosis. , 1994, Journal of the American College of Cardiology.

[30]  A. Gown,et al.  Characterization of the Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis: Histological and Immunohistochemical Studies , 1994, Circulation.

[31]  P. Libby,et al.  Diversity of T-cell antigen receptor V beta gene utilization in advanced human atheroma. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[32]  M. Rosenqvist,et al.  Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. , 1994, Journal of the American College of Cardiology.

[33]  G. Hansson,et al.  Polyclonal origin of T lymphocytes in human atherosclerotic plaques. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[34]  L. Jonasson,et al.  Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. , 1986, Clinical and experimental immunology.

[35]  G. Bondjers,et al.  Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.

[36]  W. K. Roberts,et al.  Evidence for the identity of murine gamma interferon and macrophage activating factor. , 1982, Journal of interferon research.